Effect of Central Nervous System Metastases on Treatment Discontinuation and Survival in Older Women Receiving Trastuzumab for Metastatic Breast Cancer

<table>Cumulative rate of trastuzumab discontinuation in women with metastatic breast cancer. Note: Light gray bars represent 95% confidence interval bands.</table>

Journal of Cancer Epidemiology

fig2

Figure 2

Figure 2: Effect of Central Nervous System Metastases on Treatment Discontinuation and Survival in Older Women Receiving Trastuzumab for Metastatic Breast Cancer 

Figure 2 | Effect of Central Nervous System Metastases on Treatment Discontinuation and Survival in Older Women Receiving Trastuzumab for Metastatic Breast Cancer 